Advicenne Pharma
Clinical trials sponsored by Advicenne Pharma, explained in plain language.
-
Kidney acidosis drug study pulled before it began
Disease control TerminatedThis study was designed to check the long-term safety and effectiveness of a drug called ADV7103 in people with primary distal renal tubular acidosis, a rare kidney problem that leads to too much acid in the blood. It planned to include people who had been in an earlier study, as…
Phase: PHASE3 • Sponsor: Advicenne Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Cystinuria drug trial pulled before it even started
Disease control TerminatedThis study was designed to test whether ADV7103, a combination of potassium citrate and potassium bicarbonate, could help people with cystinuria by making their urine less acidic. The goal was to see if it could raise urine pH to 7.0 or higher, which might reduce kidney stone for…
Phase: PHASE2, PHASE3 • Sponsor: Advicenne Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC